Tag: respirerx-pharmaceuticals-inc

Commercial & Investment Banking Picture Gallery

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

September 8, 2017
Presse

CEO to Review dronabinol, a Phase III-ready medicine for the treatment of Obstructive Sleep Apnea, and…

Continue Reading
Commercial & Investment Banking Picture Gallery

RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

August 25, 2017
Presse

GLEN ROCK, NJ — (Marketwired) — 08/25/17 — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the…

Continue Reading
Picture Gallery Venture Capital

RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017

February 10, 2017
Presse

CEO to review dronabinol, a Phase 3-ready medicine for the treatment of obstructive sleep apnea, and…

Continue Reading